Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.11889/5150
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBatrawi, Nidal
dc.contributor.authorShtaya, Hani Naseef
dc.contributor.authorAl-Rimawi, Fuad
dc.date.accessioned2017-08-23T06:07:13Z
dc.date.available2017-08-23T06:07:13Z
dc.date.issued2017-07-11
dc.identifier.issnhttps://doi.org/10.1155/2017/1529280
dc.identifier.urihttp://hdl.handle.net/20.500.11889/5150
dc.description.abstractThe combination of the powerful antimicrobial agent florfenicol and the nonsteroidal anti-inflammatory flunixin meglumine is used for the treatment of bovine respiratory disease (BRD) and control of BRD-associated pyrexia, in beef and nonlactating dairy cattle. This study describes the development and validation of an HPLC-UVmethod for the simultaneous determination of florfenicol and flunixin, in an injectable preparation with a mixture of excipients.The proposed RP-HPLC method was developed by a reversed phase- (RP-) C18e (250mm× 4.6 mm, 5 𝜇m) column at roomtemperature, with an isocraticmobile phase of acetonitrile and water mixture, and pH was adjusted to 2.8 using diluted phosphoric acid, a flow rate of 1.0 mL/min, and ultraviolet detection at 268 nm. The stability-indicating method was developed by exposing the drugs to stress conditions of acid and base hydrolysis, oxidation, photodegradation, and thermal degradation; the obtained degraded products were successfully separated from the APIs. This method was validated in accordance with FDA and ICH guidelines and showed excellent linearity, accuracy, precision, specificity, robustness, LOD, LOQ, and system suitability results within the acceptance criteria.en_US
dc.description.sponsorshipAdvanced Veterinary Manufacturing Company (Palestine)en_US
dc.language.isoen_USen_US
dc.publisherHindawien_US
dc.subjectInjections, Intravenousen_US
dc.subjectHigh performance liquid chromatographyen_US
dc.subjectChemistry, Analytic - Quality controlen_US
dc.subjectFlorfenicolen_US
dc.subjectFlunixin meglumineen_US
dc.subjectDrug antagonismen_US
dc.titleDevelopment and validation of a stability-indicating HPLC method for the simultaneous determination of florfenicol and flunixin meglumine combination in an injectable solutionen_US
dc.typeArticleen_US
newfileds.departmentPharmacy - Nursing and Health Professionsen_US
newfileds.custom-issue-date11 July 2017en_US
newfileds.item-access-typeopen_accessen_US
newfileds.thesis-prognoneen_US
newfileds.general-subjectHuman Biology, Medicine and Health Sciences | الطب والعلوم الطبيةen_US
Appears in Collections:Fulltext Publications



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.